Praxair

Photo

US Court Awards Huntsman Damages Against Praxair

A US court has awarded Huntsman damages in a long-running legal battle against Praxair, now part of Linde. A New Orleans jury has granted the Texas-headquartered chemical manufacturer nearly $94 million, which will exceed $125 million once the Court has applied interest.

26 more articles

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.